Elevated Prevalence Of Skin Infections Fuels Growth In The Acute Bacterial Skin And Skin Structure Infections Market Emerges as a Core Driver of the Acute Bacterial Skin And Skin Structure Infections Market in 2025

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Acute Bacterial Skin And Skin Structure Infections Market Through 2025?
The market size for acute bacterial skin and skin structure infections has seen a swift expansion recently. The growth, projected to rise from $11.75 billion in 2024 to $13.03 billion in 2025, signifies a compound annual growth rate (CAGR) of 10.9%. The surge during the historic period can be attributed to several factors including innovation in the healthcare industry, economic dynamics, trend in patient population, development in diagnostic techniques, and advancements in clinical trials.

What's the Projected Size of the Global Acute Bacterial Skin And Skin Structure Infections Market by 2029?
The market size for acute bacterial skin and skin structure infections is projected to experience robust growth in the upcoming years, reaching $18.99 billion by 2029 with a compound annual growth rate (CAGR) of 9.9%. The anticipated growth during this forecast period is due to global epidemiological factors, the introduction of new treatment therapies, the evolution of rapid diagnostic tools, a more patient-centered approach, and changes in treatment guidelines. Key trends for the forecast interval include demographic changes in the patient population, concerns about antibiotic resistance, progression in treatment strategies, incidence of methicillin-resistant staphylococcus aureus (mrsa), and emphasis on outpatient care.

View the full report here:
https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Top Growth Drivers in the Acute Bacterial Skin And Skin Structure Infections Industry: What's Accelerating the Market?
The acute bacterial skin and skin structure infections market is anticipated to experience growth as skin infections, mostly caused by microorganisms like bacteria, viruses, or fungi, become more prevalent. These infections, which invade and multiply within the skin, result in various discomforting symptoms and thus create a higher demand for therapeutic solutions, innovative treatments, and antibiotics. This demand aims to treat acute bacterial and other skin structure infections to ensure that patients receive the best care and outcomes possible. Data released in March 2023 by the World Health Organization (WHO), a specialized agency of the United Nations headquartered in Switzerland, revealed that approximately 1.8 billion people worldwide suffer from skin conditions at any given time. Neglected tropical diseases account for around 10% of these cases, while fungal infections represent 34% and bacterial infections make up 23%, often leading to high mortality rates. Consequently, the escalation of skin infections is projected to boost the acute bacterial skin and skin structure infections market. The increasing incidence of chronic diseases is another critical growth driver for the acute bacterial skin and skin structure infections market. Chronic diseases, which are medical conditions that progress slowly and last for an extended duration, often lifelong, drive up the risk of bacterial skin infections. This upswing, in turn, results in an increased need for treatments, hospitalizations, specialized care, research, public awareness campaigns, and targeted interventions for those affected, which spur the growth of this market. As reported by WHO in September 2022, non-communicable diseases (NCDs) or chronic diseases account for 74% of 41 million deaths annually worldwide. These included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Such a high prevalence rate of chronic diseases bolsters the acute bacterial skin and skin structure infections market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13282&type=smp

What Trends Will Shape the Acute Bacterial Skin And Skin Structure Infections Market Through 2029 and Beyond?
Leading firms in the acute bacterial skin and skin structure infections market are concentrating on the creation of unique single-dose treatments like Dalbonova to secure a strong position in the industry. Dalbonova is a single-dosage therapy that offers both convenience and effectiveness, allowing patients to reach their treatment goals with a single powerful 1500 mg dose. For example, BDR Pharmaceuticals Internationals Pvt. Ltd., an Indian pharmaceutical company specializing in API (active pharmaceutical ingredient) and formulation therapeutic segments, including acute bacterial skin and skin structure infections, launched Dalbonova injection in August 2023. This injection, a one-time treatment for acute bacterial skin and skin structure infections (ABSSSI), minimises the chances of diseases acquired from hospitals by providing a single-dose solution and eliminating the need for hospital stays. It's intended to combat ABSSSI caused by specific gram-positive microorganisms in patients of all age groups, including newborns.

What Are the Main Segments in the Acute Bacterial Skin And Skin Structure Infections Market?
The acute bacterial skin and skin structure infections market covered in this report is segmented -

1) By Type Of Infection: Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections, Community-Acquired Acute Bacterial Skin And Skin Structure Infections
2) By Active Ingredients: Delafloxacin, Vancomycin, Ceftaroline Fosamil, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, Other Active Ingredients
3) By Route Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Cellulitis, Abscess, Surgical Wounds, Traumatic Wound

Subsegments:
1) By Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs): Surgical Site Infections, Catheter-Related Infections, Pressure Ulcers, Infections Related To Medical Devices
2) By Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs): Cellulitis, Abscesses, Impetigo, Folliculitis, Wound Infections

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13282&type=smp

Which Top Companies are Driving Growth in the Acute Bacterial Skin And Skin Structure Infections Market?
Major companies operating in the acute bacterial skin and skin structure infections market report are Pfizer Inc., AbbVie Inc., Novartis AG, Abbott Laboratories, Fresenius SE & Co. KGaA, GSK PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Menarini Group, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Zydus Lifesciences Limited, Eurofarma Laboratórios S.A., Glenmark Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Alkem Laboratories Limited, Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Medicine Co. Ltd., Aurobindo Pharma Limited, Zhejiang Jingxin Pharmaceutical Co. Ltd., ACS Dobfar SpA, Melinta Therapeutics LLC, Shandong Luoxin Pharmaceutical Group Co. Ltd., Wakunaga Pharmaceutical Co. Ltd., Flynn Pharma Ltd.

Which Regions Will Dominate the Acute Bacterial Skin And Skin Structure Infections Market Through 2029?
Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13282

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.